ias - Monitoring
  • KI-Tools
  • Suche
  • Publizieren
  • Mediathek
Seite wählen
Global Bronchodilators Market Strategic Insights 2019 – AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline – MelodyReports

Global Bronchodilators Market Strategic Insights 2019 – AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline – MelodyReports

von Tobias Borgers | Aug. 20, 2019 | Boehringer

The Global “Bronchodilators” Market research report highlights the major details and provides in-depth analysis of the market along with the future growth, prospects and Industry demands analysis explores with the table of contents to analyze the situations of global...
Global Bronchodilators Market Strategic Insights 2019 – AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline – MelodyReports

mRNA Vaccines & Therapeutics Market SWOT Analysis by Key Players –Argos Therapeutics, AstraZeneca, Bayer, BioNTech, Boehringer Ingelheim

von Tobias Borgers | Aug. 19, 2019 | Boehringer

HTF MI newly added the mRNA Vaccines & Therapeutics Market Study that gives meticulous investigation of current scenario of the Market size, share, demand, growth, trends, and forecast in the coming years. The report firstly introduced the mRNA Vaccines &...
GEA schafft mit neuer Organisationsstruktur Basis für Leistungssteigerung

GEA schafft mit neuer Organisationsstruktur Basis für Leistungssteigerung

von Tobias Borgers | Aug. 19, 2019 | GEA

Der Technologiekonzern GEA hat die Grundzüge seiner neuen Organisationsstruktur vorgestellt, die bereits ab dem 1. Oktober 2019 schrittweise eingeführt wird und offiziell zum 1. Januar 2020 in Kraft tritt. GEA wird sich zukünftig in fünf Divisionen mit jeweils bis zu...
Injectable Drug Delivery Market Growth, Opportunities, Statistics, Segment, Trends, Size, Share, Type, Demand and Forecast 2017 to 2025

Injectable Drug Delivery Market Growth, Opportunities, Statistics, Segment, Trends, Size, Share, Type, Demand and Forecast 2017 to 2025

von Tobias Borgers | Aug. 19, 2019 | Continuous Manufacturing

Global Injectable Drug Delivery Market: Snapshot The provision of maximum and quickest form of bioavailability of the administered drug continues to remain one of the key factors why injectable drug delivery continues to remain one of the most popular ways of...
Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia

Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia

von Tobias Borgers | Aug. 19, 2019 | Roche

Media Release Basel, 16 May 2019 Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia Fixed 12-month treatment with Venclexta plus Gazyva significantly reduced risk of disease progression or death by...
« Ältere Einträge
Nächste Einträge »

Kategorien

Schlagwörter

Breaking News Kunden Location Production Products prozesstechnik online Wettbewerb
  • Backend
  • Alle Beiträge
  • Dokumentation
  • Logout